Epidemiologic methods

Dr. Weiss has been an epidemiologist for 50 years. While much of his work has been directed towards cancer epidemiology and epidemiologic methods, he has had a consistent interest in clinical epidemiology, i.e. the study of the outcome of illness. In 1986, he published a book on this subject - Clinical Epidemiology: The Study of the Outcome of Illness (Monographs in Epidemiology and Biostatistics, 36) - which is now in its third edition.

Paul Dluzniewski is currently a Director in the Center for Observational Research at Amgen. As product area lead for the cardiovascular-metabolic group, his work is focused on therapies used to treat patients at elevated risk of cardiovascular disease. He leads evidence generation efforts by conducting epidemiologic research to inform the benefit-risk profile of Amgen’s therapies and highlight the clinical value of both marketed and pipeline products.

Marissa Seamans, PhD, MSPH, is an Assistant Professor in the Department of Epidemiology. Dr. Seamans’ research focuses on the intersection of social epidemiology and pharmacoepidemiology to address substance use and mental health. Her work explores the use of large healthcare databases to examine prescription drug use in families and the effectiveness of treatments for mental health and substance use disorders. Methodologically, Dr.

Dr. Joseph Davey's research focuses on how best to prevent and treat HIV and other sexually transmitted infections in peri-conception, pregnant women and couples, as well as other vulnerable populations. She has expertise in study design and use of epidemiological methods to inform interventions aimed at reducing the burden of HIV and related diseases on women, children, and families.

Roch Nianogo is an Assistant Professor in the Department of Epidemiology at the UCLA Fielding School of Public Health. He is a physician and scientist of preventive medicine and epidemiologist. Dr. Nianogo’s research strives to help reduce the burden of preventable chronic diseases, promote the health and wellbeing of patients and populations, especially those most vulnerable, and assist clinical, public health and policy decision-making. To this end, Dr. Nianogo has developed research interests that are both methodological and substantive in nature.

Elizabeth Rose Mayeda (she/her) is an Associate Professor in the Department of Epidemiology at the UCLA Fielding School of Public Health. Dr. Mayeda's research focuses on identifying modifiable determinants of cognitive decline, dementia, and stroke in late life. Her research program has both applied and methodological themes. She focuses on describing and identifying mechanisms contributing to disparities in late-life cognitive and brain health and also leads work addressing methodological challenges in longitudinal studies of stroke, cognitive aging, and dementia risk.